Updated meta-analysis for antihypertensive treatment guided by home blood pressure compared to treatment based on office blood pressure: systematic review
- PMID: 39719531
- DOI: 10.1038/s41440-024-02072-0
Updated meta-analysis for antihypertensive treatment guided by home blood pressure compared to treatment based on office blood pressure: systematic review
Abstract
Home blood pressure (BP) measurement is widely used, and home BP plays a central role in hypertension management in clinical practice in Japan. We updated the systematic review to determine whether home BP-based antihypertensive treatment is superior to office BP-based treatment in improving clinical outcomes, including BP levels, in adult patients with essential hypertension. A literature search identified 14 randomized controlled trials (RCTs). The results of meta-analysis revealed that home BP-based antihypertensive treatment was significantly associated with greater reductions in ambulatory systolic BP by 2.73 mmHg (95% confidence interval [CI], -5.23 to -2.22 mmHg; p = 0.03) and ambulatory diastolic BP by 1.61 mmHg (95% CI, -3.21 to -0.01 mmHg; p = 0.05) compared to office BP-based treatment. No RCTs evaluating cardiovascular outcomes other than ambulatory BP reduction were identified. Consistent with the previous review, this updated meta-analysis revealed home BP-based antihypertensive treatment is strongly recommended over office BP-based treatment for BP control in patients with essential hypertension.
Keywords: Ambulatory blood pressure; Home blood pressure; Meta-analysis; Office blood pressure.
© 2024. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: TO received honoraria (lecture fee) and a joint research grant from Omron Healthcare Co., Ltd.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical